Safety and Feasibility of Biweekly Divided-dose of DCF as Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma
Anticancer Research · 2026-08 · 46 (8) · 4461-4469
DOI: 10.21873/anticanres.18302 ↗Kurz gefasst
Fachartikel in der Zeitschrift Anticancer Research, online erschienen am 29.07.2026. Verfasst von Tatsuro Tamura und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; d21528w@omu.ac.jp. Hauptthemen laut MEDLINE: Neoadjuvant Therapy, Fluorouracil, Esophageal Squamous Cell Carcinoma, Antineoplastic Combined Chemotherapy Protocols.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan; d21528w@omu.ac.jp.
- Department of Gastroenterological Surgery, Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan.
- Department of Gastroenterological Surgery, Nakagami Hospital, Okinawa, Japan.
- Department of Gastroenterological Surgery, Osaka City General Hospital, Osaka, Japan.
- Department of Surgery, Baba Memorial Hospital, Sakai, Japan.
Zitieren
APA
Tamura, T., Toyokawa, T., Lee, S., Ishidate, T., Sakurai, K., Kubo, N., Deguchi, S., Seki, Y., Kuroda, K., Kasashima, H., Miki, Y., Yoshii, M., Shibutani, M., Ohira, M., & Maeda, K. (2026). Safety and Feasibility of Biweekly Divided-dose of DCF as Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Anticancer Research, 46(8), 4461-4469. https://doi.org/10.21873/anticanres.18302
Vancouver
Tamura T, Toyokawa T, Lee S, Ishidate T, Sakurai K, Kubo N, et al. Safety and Feasibility of Biweekly Divided-dose of DCF as Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma. Anticancer Research. 2026;46(8):4461-4469. doi:10.21873/anticanres.18302
BibTeX
@article{Tamura2026,
author = {Tamura, Tatsuro and Toyokawa, Takahiro and Lee, Shigeru and Ishidate, Takemi and Sakurai, Katsunobu and Kubo, Naoshi and Deguchi, Sota and Seki, Yuki and Kuroda, Kenji and Kasashima, Hiroaki and Miki, Yuichiro and Yoshii, Mami and Shibutani, Masatsune and Ohira, Masaichi and Maeda, Kiyoshi},
title = {Safety and Feasibility of Biweekly Divided-dose of DCF as Neoadjuvant Chemotherapy for Esophageal Squamous Cell Carcinoma},
journal = {Anticancer Research},
year = {2026},
volume = {46},
number = {8},
pages = {4461--4469},
doi = {10.21873/anticanres.18302}
}
EUVIMED